These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26343140)

  • 1. Combination of DC Vaccine and Conventional Chemotherapeutics.
    Dong W; Wei R; Shen H; Ni Y; Meng L; Du J
    Anticancer Agents Med Chem; 2016; 16(5):558-67. PubMed ID: 26343140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
    Versteven M; Van den Bergh JMJ; Marcq E; Smits ELJ; Van Tendeloo VFI; Hobo W; Lion E
    Front Immunol; 2018; 9():394. PubMed ID: 29599770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dendrite cell-based cancer vaccines--clinical application].
    Svane IM; Berntsen A; Trepiakas R; Pedersen AE
    Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy.
    Ashraf MU; Jeong Y; Roh SE; Bae YS
    Arch Pharm Res; 2019 Jul; 42(7):582-590. PubMed ID: 30937843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.
    Bol KF; Schreibelt G; Gerritsen WR; de Vries IJ; Figdor CG
    Clin Cancer Res; 2016 Apr; 22(8):1897-906. PubMed ID: 27084743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma.
    Jie X; Hua L; Jiang W; Feng F; Feng G; Hua Z
    Cell Biochem Biophys; 2012 Jan; 62(1):91-9. PubMed ID: 21909820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing efficacy of therapeutic vaccinations by combination with other modalities.
    Gulley JL; Madan RA; Arlen PM
    Vaccine; 2007 Sep; 25 Suppl 2(Suppl 2):B89-96. PubMed ID: 17573164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
    Antonia SJ; Mirza N; Fricke I; Chiappori A; Thompson P; Williams N; Bepler G; Simon G; Janssen W; Lee JH; Menander K; Chada S; Gabrilovich DI
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):878-87. PubMed ID: 16467102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.
    Li J; Aipire A; Li J; Zhu H; Wang Y; Guo W; Li X; Yang J; Liu C
    Oncotarget; 2017 May; 8(18):29996-30007. PubMed ID: 28404904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
    Fecek RJ; Storkus WJ
    Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.
    Truxova I; Hensler M; Skapa P; Halaska MJ; Laco J; Ryska A; Spisek R; Fucikova J
    Int Rev Cell Mol Biol; 2017; 330():115-156. PubMed ID: 28215530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
    Saadeldin MK; Abdel-Aziz AK; Abdellatif A
    Med Hypotheses; 2021 Jan; 146():110365. PubMed ID: 33221134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat.
    Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH
    Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of dendritic cell tumor-vaccine with dendritic cells and problems in its clinical uses--review].
    Yu ZY; Chen H; Feng K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):397-400. PubMed ID: 15228677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.
    Garg AD; Coulie PG; Van den Eynde BJ; Agostinis P
    Trends Immunol; 2017 Aug; 38(8):577-593. PubMed ID: 28610825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccines: A review of recent developments and their potential pediatric application.
    Elster JD; Krishnadas DK; Lucas KG
    Hum Vaccin Immunother; 2016 Sep; 12(9):2232-9. PubMed ID: 27245943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccine and cancer treatment: new patents.
    Aleixo AA; Michelin MA; Murta EF
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):26-9. PubMed ID: 24397783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.